(Q38582187)

English

Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha

scientific article published on 05 October 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha (English)

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

0 references

psoriatic arthritis

1 reference

based on heuristic

inferred from title

Giovanna D'Agosto

3

0 references

object named as

Anna Mussi

5

0 references

Valentina Bordignon

object named as

Valentina Bordignon

4

0 references

Fabrizio Ensoli

object named as

Fabrizio Ensoli

11

0 references

author name string

Paola Cordiali-Fei

1

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Elisabetta Trento

2

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Marco Ardigò

6

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Antonio Mastroianni

7

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Antonella Vento

8

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Francesco Solivetti

9

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Enzo Berardesca

10

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

publication date

5 October 2006

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Journal of autoimmune diseases

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

3

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

5

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

copyright license

Creative Commons Attribution 2.0 Generic

5 October 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

0 references

Anti-TNF-alpha agents in the treatment of psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Classification and diagnostic criteria for psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Matrix metalloproteinases as modulators of inflammation and innate immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Infliximab for psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Cytokines in psoriasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

The pathogenesis of psoriasis: immunological facts and speculations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

6 September 2017

Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

27 September 2017

Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

27 September 2017

Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

23 June 2018

Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

23 June 2018

Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

31 August 2018

Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

31 August 2018

Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

31 August 2018

MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

31 August 2018

Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1601955

31 August 2018

Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine profiles during infliximab monotherapy in psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of lesional skin corneometry values with serum E-selectin levels and disease severity in patients affected by plaque-type psoriasis: recovery after effective therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17022813

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1740-2557-3-5

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38582187&oldid=2201850297"